|
1
|
Marks DI, Alonso L and Radia R: Allogeneic
hematopoietic cell transplantation in adult patients with acute
lymphoblastic leukemia. Hematol Oncol Clin North Am. 28:995–1009.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ge L, Ye F, Mao X, Chen J, Sun A, Zhu X,
Qiu H, Jin Z, Miao M, Fu C, et al: Extramedullary relapse of acute
leukemia after allogeneic hematopoietic stem cell transplantation:
Different characteristics between acute myelogenous leukemia and
acute lymphoblastic leukemia. Biol Blood Marrow Transplant.
20:1040–1047. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martinelli G, Trabetti E, Farabegoli P,
Testoni N, Bandini G, Motta MR, Vittone A, Terragna C, Pignatti PF
and Tura S: Early detection of bone marrow engraftment by
amplification of hypervariable DNA regions. Haematologica.
82:156–160. 1997.PubMed/NCBI
|
|
4
|
Gökbuget N, Hoelzer D, Arnold R, Böhme A,
Bartram CR, Freund M, Ganser A, Kneba M, Langer W, Lipp T, et al:
Treatment of adult ALL according to protocols of the German
multicenter study group for adult ALL (GMALL). Hematol Oncol Clin
North Am. 141307–1325. (ix)2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pulte D, Jansen L, Gondos A, Katalinic A,
Barnes B, Ressing M, Holleczek B, Eberle A and Brenner H: GEKID
Cancer Survival Working Group: Survival of adults with acute
lymphoblastic leukemia in Germany and the United States. PLoS One.
9:e855542014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frey NV and Luger SM: How I treat adults
with relapsed or refractory Philadelphia chromosome-negative acute
lymphoblastic leukemia. Blood. 126:589–596. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nabhan C, Tolentino A, Meyer A and Tallman
MS: Cutaneous involvement with B-lineage acute lymphoblastic
leukemia. Leuk Lymphoma. 53:987–989. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Doney K, Hägglund H, Leisenring W,
Chauncey T, Appelbaum FR and Storb R: Predictive factors for
outcome of allogeneic hematopoietic cell transplantation for adult
acute lymphoblastic leukemia. Biol Blood Marrow Transplant.
9:472–481. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hunault M, Harousseau JL, Delain M,
Truchan-Graczyk M, Cahn JY, Witz F, Lamy T, Pignon B, Jouet JP,
Garidi R, et al: Better outcome of adult acute lymphoblastic
leukemia after early genoidentical allogeneic bone marrow
transplantation (BMT) than after late high-dose therapy and
autologous BMT: A GOELAMS trial. Blood. 104:3028–3037. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yanada M, Matsuo K, Suzuki T and Naoe T:
Allogeneic hematopoietic stem cell transplantation as part of
postremission therapy improves survival for adult patients with
high-risk acute lymphoblastic leukemia: A metaanalysis. Cancer.
106:2657–2663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marks DI, Pérez WS, He W, Zhang MJ, Bishop
MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, et al:
Unrelated donor transplants in adults with Philadelphia-negative
acute lymphoblastic leukemia in first complete remission. Blood.
112:426–434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fielding AK, Rowe JM, Richards SM, Buck G,
Moorman AV, Durrant IJ, Marks DI, McMillan AK, Litzow MR, Lazarus
HM, et al: Prospective outcome data on 267 unselected adult
patients with Philadelphia chromosome-positive acute lymphoblastic
leukemia confirms superiority of allogeneic transplantation over
chemotherapy in the pre-imatinib era: Results from the
International ALL Trial MRC UKALLXII/ECOG2993. Blood.
113:4489–4496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duval M, Klein JP, He W, Cahn JY, Cairo M,
Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, et al:
Hematopoietic stem-cell transplantation for acute leukemia in
relapse or primary induction failure. J Clin Oncol. 28:3730–3738.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozlowski P, Åström M, Ahlberg L, Bernell
P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A,
Tomaszewska-Toporska B, Smedmyr B and Hallböök H: High curability
via intensive reinduction chemotherapy and stem cell
transplantation in young adults with relapsed acute lymphoblastic
leukemia in Sweden 2003–2007. Haematologica. 97:1414–1421. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sullivan KM, Weiden PL, Storb R,
Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C,
Appelbaum FR, Badger C, et al: Influence of acute and chronic
graft-versus-host disease on relapse and survival after bone marrow
transplantation from HLA-identical siblings as treatment of acute
and chronic leukemia. Blood. 73:1720–1728. 1989.PubMed/NCBI
|
|
16
|
Horowitz MM, Gale RP, Sondel PM, Goldman
JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B, et
al: Graft-versus-leukemia reactions after bone marrow
transplantation. Blood. 75:555–562. 1990.PubMed/NCBI
|
|
17
|
Passweg JR, Tiberghien P, Cahn JY, Vowels
MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah
N, et al: Graft-versus-leukemia effects in T lineage and B lineage
acute lymphoblastic leukemia. Bone Marrow Transplant. 21:153–158.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JH, Choi SJ, Lee JH, Seol M, Lee YS,
Ryu SG, Park CJ, Chi HS, Lee MS, Yun S, et al: Anti-leukemic effect
of graft-versus-host disease on bone marrow and extramedullary
relapses in acute leukemia. Haematologica. 90:1380–1388.
2005.PubMed/NCBI
|
|
19
|
Shi JM, Meng XJ, Luo Y, Tan YM, Zhu XL,
Zheng GF, He JS, Zheng WY, Xie WZ, Li L, et al: Clinical
characteristics and outcome of isolated extramedullary relapse in
acute leukemia after allogeneic stem cell transplantation: A
single-center analysis. Leuk Res. 37:372–377. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong YC, Liu HM, Chen PS, Chen YJ, Lyou
JY, Hu HY, Yi MF, Lin JS and Tzeng CH: Hair follicle: A reliable
source of recipient origin after allogeneic hematopoietic stem cell
transplantation. Bone Marrow Transplant. 40:871–874. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Willemze AJ, Bakker AC, von dem Borne PA,
Bajema IM and Vossen JM: The effect of graft-versus-host disease on
skin endothelial and epithelial cell chimerism in stem-cell
transplant recipients. Transplantation. 87:1096–1101. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murata H, Janin A, Leboeuf C, Soulier J,
Gluckman E, Meignin V and Socie G: Donor-derived cells and human
graft-versus-host disease of the skin. Blood. 109:2663–2651. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Imanishi D, Miyazaki Y, Yamasaki R,
Sawayama Y, Taguchi J, Tsushima H, Fukushima T, Yoshida S, Sasaki
H, Hata T and Tomonaga M: Donor-derived DNA in fingernails among
recipients of allogeneic hematopoietic stem-cell transplants.
Blood. 110:2231–2234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pearce L, Lim ZY, Usai M, Ho AY, Mufti GJ
and Pagliuca A: Mixed donor chimaerism in recipient fingernails
following reduced-intensity conditioning haematopoietic SCT. Bone
Marrow Transplant. 42:361–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kalayoglu-Besisik S, Oguz FS, Aydin F,
Duvarci Y, Sargin D and Carin M: Tissue chimerism analysis after
donor lymphocyte infusion: A case of deceptive evidence.
Hematology. 13:92–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
